Acta Scientific Pharmacology

Editorial Volume 2 Issue 1

The Haemocytic Haversack- Myospherulosis

Anubha Bajaj*

Department of Histopathology, Panjab University/A.B. Diagnostics, India

*Corresponding Author: Anubha Bajaj, Department of Histopathology, Panjab University/A.B. Diagnostics, India.

Received: November 24, 2020; Published: November 30, 2020

×

Preface

  Myospherulosis is an exceptional disorder with distinctive histological features comprised of a granulomatous reaction to aggregates of denatured erythrocytes interacting with endogenous and exogenous lipid-rich substances. Myospherulosis was initially scripted by McClatchie in 1969 as an uncommon, chronic inflammatory disorder demonstrating soft tissue nodules appearing as fungi-like spherules composed of red cell extravasation delineated upon sites of preceding intramuscular injections [1].

×

Citation

Citation: Anubha Bajaj. “The Haemocytic Haversack- Myospherulosis".Acta Scientific Pharmacology 2.1 (2021): 01-04.




Metrics

Acceptance rate36%
Acceptance to publication20-30 days

Indexed In


News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is September 30, 2021.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US